Gufic BioSciences Ltd: Stock Analysis & Fundamentals

Updated this week

Gufic BioSciences Ltd (Pharma - Formulators) — fundamental analysis, earnings data, and key metrics. PE: 56.2. ROE: 12.3%. This stock is not currently in the Nifty 500 momentum outperformers list.

What's Happening

🏛️DII accumulation — stake up 1.2%

Key Numbers

Current Price

₹280

Dividend Yield

0.04%

Market Cap

2.8K Cr

Valuation

N/A

Other Top Pharma - Formulators Stocks Beating Nifty 500

Sun Pharmaceutical Industries Ltd

Strong • 4w streak

+15.9%

Torrent Pharmaceuticals Ltd

Average • 12w streak

+23.4%

Dr Reddys Laboratories Ltd

Zydus Lifesciences Ltd

Weak

+10.0%

← Back to Pharma - Formulators Dashboard

Frequently Asked Questions: Gufic BioSciences Ltd

Based on publicly available financial data. This is educational research, not investment advice.

What were Gufic BioSciences Ltd's latest quarterly results?

Gufic BioSciences Ltd's latest quarterly results (Dec 2025) show

PAT Growth YoY: -36.8%
Revenue Growth YoY: +11.1%
Operating Margin: 14.0%

What is Gufic BioSciences Ltd's current PE ratio?

Gufic BioSciences Ltd's current PE ratio is 56.2x.

Current PE: 56.2x
Market Cap: 2.8K Cr
Dividend Yield: 0.04%

What is Gufic BioSciences Ltd's price-to-book ratio?

Gufic BioSciences Ltd's price-to-book ratio is 4.5x.

Price-to-Book (P/B): 4.5x
Book Value per Share: ₹63
Current Price: ₹280

Is Gufic BioSciences Ltd a fundamentally strong company?

Gufic BioSciences Ltd's fundamental strength based on key financial ratios

Return on Capital (ROCE): 13.0%

Is Gufic BioSciences Ltd debt free?

Gufic BioSciences Ltd has a debt-to-equity ratio of N/A.

Total Debt: ₹336 Cr

What is Gufic BioSciences Ltd's return on equity (ROE) and ROCE?

Gufic BioSciences Ltd's return ratios over recent years

FY2025: ROCE 13.0%

Is Gufic BioSciences Ltd's cash flow positive?

Gufic BioSciences Ltd's operating cash flow is positive (FY2025).

Cash from Operations (CFO): ₹123 Cr
Free Cash Flow (FCF): ₹52 Cr
CFO/PAT Ratio: 176% (strong cash conversion)

What is Gufic BioSciences Ltd's dividend yield?

Gufic BioSciences Ltd's current dividend yield is 0.04%.

Dividend Yield: 0.04%
Current Price: ₹280

Who holds Gufic BioSciences Ltd shares — promoters, FII, DII?

Gufic BioSciences Ltd's shareholding pattern (Dec 2025)

Promoters: 72.5%
FII (Foreign): 0.4%
DII (Domestic): 3.7%
Public: 23.3%

Is promoter holding increasing or decreasing in Gufic BioSciences Ltd?

Gufic BioSciences Ltd's promoter holding has remained stable recently.

Current Promoter Holding: 72.5% (Dec 2025)
Previous Quarter: 72.5% (Sep 2025)
Change: 0.00% (stable)

Is Gufic BioSciences Ltd a new momentum entry or an established outperformer?

Gufic BioSciences Ltd is an established outperformer with 1 weeks of consecutive Nifty 500 outperformance.

Is Gufic BioSciences Ltd worth studying for long term investment?

Based on quantitative research signals, here is why Gufic BioSciences Ltd may be worth studying

Cash flow is positive — CFO ₹123 Cr

What is the investment thesis for Gufic BioSciences Ltd?

Gufic BioSciences Ltd investment thesis summary:

What is the future outlook for Gufic BioSciences Ltd?

Gufic BioSciences Ltd's forward outlook based on current data signals

Insufficient data for a forward assessment — monitoring for more signals

The above FAQs are generated from publicly available earnings data and conference call transcripts. This is educational research only. Sector Alpha is not SEBI registered and does not provide investment advice.